SHERILYN BRINKLEY: Open Payments
NPI 1487612099 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,737 in 43 payments from 2 companies in 2025. Trend: 2023 $22,772 · 2024 $20,681 · 2025 $17,737
Speaker / faculty: $11,800Travel & lodging: $4,823Food & beverage: $1,114
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 31 | $14,570 |
| ABBVIE INC. | 12 | $3,167 |
Products named: Epclusa, MAVYRET.
Industry payments across MD — which companies pay providers there.
